News & Events > Events > Very Rare Cancer Consortium Disease Spotlight & Research Roundtable

Very Rare Cancer Consortium Disease Spotlight & Research Roundtable

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions.

Disease Spotlight & Research Roundtable

Please note registration is required.

Hepatoblastoma is the most common liver neoplasm in children and accounts for 1% of all childhood malignancies. Over the last decade, the incidence of Hepatoblastoma has nearly doubled, faster than any other childhood cancer, however in this time we have gained little ground in understanding the molecular characteristics that drive the disease. The five-year survival for Hepatoblastoma is estimated at 60-70%, one of the lowest survival rates for childhood cancer, demanding translational studies to improve our understanding of the disease and enable the development of targeted and more effective clinical therapies.

During this VRCC Roundtable focused on Hepatoblastoma, we will hear from a panel of experts and discuss our current understanding of the disease, advances being made in treatment and research, studies needed to improve patient care, and how we might be able to work together to move to field forward.

Any questions on this event, contact


  • Robert E. Schwartz, MD, PhD

    Assistant Professor of Medicine
    Division of Gastroenterology and Hepatology
    Weill Cornell Medicine

  • Allison O'Neill, MD

    Clinical Director, Solid Tumor Center
    Director of Medical Therapies, Liver Tumor CenterSenior Physician
    Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
    Assistant Professor of Pediatrics
    Harvard Medical School

  • Dolores López-Terrada, MD, PhD

    Professor of Pathology and Pediatrics
    Baylor College of Medicine
    Division Chief, Genomic Medicine
    Texas Children’s Hospital Department of Pathology

  • Logan G. Spector, PhD

    Suzanne Holmes Hodder Chair in Pediatric Cancer
    Research Director, Division of Epidemiology/Clinical Research
    Department of Pediatrics
    University of Minnesota

  • Eiso Hiyama, MD, PhD

    Professor, Department of Pediatric Surgery
    Hiroshima University Hospital
    Director, Natural Science Center for Basic Research and Development (N-BARD)
    Hiroshima University

  • Shauna L. Houlihan, PhD

    Associate Director of Liver Research
    Englander Institute for Precision Medicine
    Weill Cornell Medicine
    Scientific Director, Very Rare Cancer Consortium
    New York Genome Center

  • James I. Geller, MD

    Director – Liver, Kidney and Retinoblastoma Programs, Cancer and Blood Diseases Institute
    Director, Advanced Cancer Therapy Network, Cancer and Blood Disease Institute
    Director, Pilot Translational Core Grant Program, Center for Clinical and Translational Science and Training
    Professor, UC Department of Pediatrics
    Cincinnati Children’s Hospital Medical Center

Decorative image color fade left Decorative image color fade right Decorative image color fade